Primary biliary cholangitis (PBC) is a chronic, cholestatic, autoimmune disease with a
variable progressive course. PBC can cause debilitating symptoms including fatigue and …

This American Association for the Study of Liver Diseases (AASLD) 2018 Practice Guidance
on Primary Biliary Cholangitis (PBC) is an update of the PBC guidelines published in 2009 …

Primary biliary cholangitis (PBC) is a chronic inflammatory autoimmune cholestatic liver
disease, which when untreated will culminate in end-stage biliary cirrhosis. Diagnosis is …

Primary biliary cholangitis (formerly known as primary biliary cirrhosis, PBC) is an
autoimmune liver disease in which a cycle of immune mediated biliary epithelial cell injury …

Background & Aims Approaches to risk stratification for patients with primary biliary cirrhosis
(PBC) are limited, single-center based, and often dichotomous. We aimed to develop and …

The biochemical response to ursodeoxycholic acid (UDCA)—so‐called “treatment
response”—strongly predicts long‐term outcome in primary biliary cholangitis (PBC) …

Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are infrequent
autoimmune cholestatic liver diseases, that disproportionate to their incidence and …

METHODS: The patient cohort from the GLOBAL PBC Study Group was used, comprising of
long-term follow-up data from European and North American centers. Ursodeoxycholic acid …

Objective Hepatocellular carcinoma (HCC) is an infrequent yet critical event in primary
biliary cirrhosis (PBC); however, predictive tools remain ill-defined. Our objective was to …

OBJECTIVES: Adding fibrates improves liver biochemistries in patients with primary biliary
cholangitis (PBC) and suboptimal response to ursodeoxycholic acid (UDCA). As there are …